General Information of Drug (ID: DMAGE91)

Drug Name
RG7800 Drug Info
Indication
Disease Entry ICD 11 Status REF
Spinal muscular atrophy 8B61 Phase 1/2 [1]
Cross-matching ID
PubChem CID
89741565
ChEBI ID
CHEMBL4459971
TTD Drug ID
DMAGE91

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Zolgensma DM57O90 Spinal muscular atrophy 8B61 Approved [3]
LMI070 DM4OAIU Spinal muscular atrophy 8B61 Phase 3 [4]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Survival motor neuron protein (SMN1) TT8QL6X SMN_HUMAN Modulator [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800039744)
2 Assays for the Identification and Prioritization of Drug Candidates for Spinal Muscular Atrophy. Assay Drug Dev Technol. 2014 August 1; 12(6): 315-341.
3 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services.
4 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)